HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS

隐球菌发病机制中的宿主因素

基本信息

  • 批准号:
    9284385
  • 负责人:
  • 金额:
    $ 40.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-15 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Host factors in cryptococcal pathogenesis PROJECT SUMMARY Cryptococcus neoformans is an opportunistic pathogen responsible for life-threatening disease in patients with AIDS or otherwise compromised immunity; extrapulmonary cryptococcal infection is an AIDS-defining illness. Cryptococcosis has a tremendous impact on human health, causing over one million cases of meningitis and 625,000 deaths annually worldwide, with the vast majority of deaths occurring in individuals with AIDS. The long-term goal of our studies is to define host:fungal interactions in C. neoformans pathogenesis, in order to improve both fundamental understanding of these important events and the outcome of this devastating AIDS- related opportunistic infection. This application focuses on the interactions between C. neoformans and host phagocytes, which have been implicated in fungal latency, dissemination, and virulence. Although fungal en- gulfment has been broadly described, little is known about the host factors required to mediate this process, a lack of understanding that impairs our ability to influence this interaction in favor of the host. We recently com- pleted an siRNA screen in a human macrophage-like cell line to identify kinases and phosphatases that act in C. neoformans internalization. We have now shown that two kinases, one involved in cell signaling and one in cell surface modification, are required for efficient fungal internalization b host primary cells. Mice lacking the signaling protein also show reduced dissemination of cryptococcal infection to the brain. We propose to deter- mine the mechanisms of action by which each of these proteins influences phagocytosis, and their effects on the pathogenesis of cryptococcal disease. We will use mouse models and primary cells in focused studies that exploit our expertise in biochemistry, gene expression, host biology, and post-translational modifications to de- termine mechanism. This powerful combination of approaches will elucidate crucial events of pathogenesis that determine survival and dissemination of an opportunistic microbe, and thereby the host's ability to limit disease. Our findings will also illuminate other host:microbe interactions and may suggest new directions for antifungal therapy.
项目概述:新型隐球菌是一种机会致病菌,可导致艾滋病患者或免疫力低下患者罹患危及生命的疾病;肺外隐球菌感染是一种艾滋病定义疾病。隐球菌病对人类健康产生巨大影响,每年在全世界造成100多万例脑膜炎和62.5万例死亡,其中绝大多数死亡发生在艾滋病患者身上。我们研究的长期目标是确定新生假丝酵母菌发病机制中宿主与真菌的相互作用,以提高对这些重要事件和这种毁灭性的艾滋病相关机会性感染结果的基本理解。该应用程序的重点是新生C.与宿主吞噬细胞之间的相互作用,这涉及真菌的潜伏期,传播和毒力。尽管真菌侵染已被广泛描述,但对介导这一过程所需的宿主因素知之甚少,缺乏理解损害了我们影响这种有利于宿主的相互作用的能力。我们最近在人类巨噬细胞样细胞系中完成了siRNA筛选,以鉴定在新生巨噬细胞内化中起作用的激酶和磷酸酶。我们现在已经证明两种激酶,一种参与细胞信号传导,另一种参与细胞表面修饰,是宿主原代细胞有效的真菌内化所必需的。缺乏这种信号蛋白的小鼠也表现出隐球菌感染向大脑传播的减少。我们建议研究这些蛋白影响吞噬的作用机制,以及它们对隐球菌病发病机制的影响。我们将在重点研究中使用小鼠模型和原代细胞,利用我们在生物化学、基因表达、宿主生物学和翻译后修饰方面的专业知识来确定机制。这种强有力的方法组合将阐明决定机会性微生物生存和传播的发病机制的关键事件,从而阐明宿主限制疾病的能力。我们的发现也将阐明其他宿主与微生物的相互作用,并可能为抗真菌治疗提供新的方向。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Maintenance of Mitochondrial Morphology in Cryptococcus neoformans Is Critical for Stress Resistance and Virulence.
维持密码球菌中线粒体形态对于应激性和毒力至关重要。
  • DOI:
    10.1128/mbio.01375-18
  • 发表时间:
    2018-11-06
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Chang AL;Doering TL
  • 通讯作者:
    Doering TL
An Automated Assay to Measure Phagocytosis of Cryptococcus neoformans.
测量新生隐球菌吞噬作用的自动测定。
  • DOI:
    10.1002/cpmc.79
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chang,AndrewL;Hole,CamaronR;Doering,TamaraL
  • 通讯作者:
    Doering,TamaraL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tamara L Doering其他文献

Tamara L Doering的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tamara L Doering', 18)}}的其他基金

Filling gaps in the cryptococcal wall with glycogen and a novel enzyme
用糖原和一种新型酶填充隐球菌壁的间隙
  • 批准号:
    10648839
  • 财政年份:
    2023
  • 资助金额:
    $ 40.87万
  • 项目类别:
Leveraging genomic approaches to define sterol transport in Cryptococcus neoformans
利用基因组方法定义新型隐球菌中的甾醇转运
  • 批准号:
    10727128
  • 财政年份:
    2023
  • 资助金额:
    $ 40.87万
  • 项目类别:
Natural genomic variants that influence cryptococcal pathogenicity
影响隐球菌致病性的自然基因组变异
  • 批准号:
    10647845
  • 财政年份:
    2020
  • 资助金额:
    $ 40.87万
  • 项目类别:
Natural genomic variants that influence cryptococcal pathogenicity
影响隐球菌致病性的自然基因组变异
  • 批准号:
    10437750
  • 财政年份:
    2020
  • 资助金额:
    $ 40.87万
  • 项目类别:
Natural genomic variants that influence cryptococcal pathogenicity
影响隐球菌致病性的自然基因组变异
  • 批准号:
    10206032
  • 财政年份:
    2020
  • 资助金额:
    $ 40.87万
  • 项目类别:
CRYPTOCOCCAL GLYCAN SYNTHESIS
隐球菌聚糖合成
  • 批准号:
    9927569
  • 财政年份:
    2018
  • 资助金额:
    $ 40.87万
  • 项目类别:
CRYPTOCOCCAL GLYCAN SYNTHESIS
隐球菌聚糖合成
  • 批准号:
    10153676
  • 财政年份:
    2018
  • 资助金额:
    $ 40.87万
  • 项目类别:
CRYPTOCOCCAL GLYCAN SYNTHESIS
隐球菌聚糖合成
  • 批准号:
    10406884
  • 财政年份:
    2018
  • 资助金额:
    $ 40.87万
  • 项目类别:
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANS
新生隐球菌中的聚糖前体运输
  • 批准号:
    8823633
  • 财政年份:
    2014
  • 资助金额:
    $ 40.87万
  • 项目类别:
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANS
新生隐球菌中的聚糖前体运输
  • 批准号:
    8709197
  • 财政年份:
    2014
  • 资助金额:
    $ 40.87万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 40.87万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 40.87万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 40.87万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 40.87万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 40.87万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 40.87万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 40.87万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 40.87万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 40.87万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 40.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了